Effect of Squeezable Bottle Nasal Irrigation Device in Children With Sinusitis
NCT ID: NCT02191046
Last Updated: 2014-11-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2013-03-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Complication of Gentamicin Nasal Irrigation in Chronic Rhinosinusitis
NCT01430026
Comparing the Use of Saline or Saline Plus Gentamycin in Nasal Irrigation to Treat Chronic Sinusitis in Children
NCT00465530
The Efficacy and Complication of Gentamicin Nasal Irrigation in Chronic Rhinosinusitis and Recurrent Sinusitis
NCT02582099
Comparison of Nasal Saline Irrigation Bottle Contamination Between Two Solutions
NCT02413125
Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms
NCT07262450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
syringe 20 ml
nasal irrigation with syringe by using buffer hypertonic saline about 100-240 ml until no nasal discharge
syringe 20 ml
nasal irrigation twice daily for 2 weeks
squeezable bottle
nasal irrigation with squeezable bottle by using buffer hypertonic saline about 100-240 ml until no nasal discharge
squeezable bottle
nasal irrigation twice daily for 2 weeks period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
squeezable bottle
nasal irrigation twice daily for 2 weeks period
syringe 20 ml
nasal irrigation twice daily for 2 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. diagnose sinusitis by each of following criteria 2.1 persistent upper respiratory infection symptoms \> or = 10 days 2.2. severe upper respiratory infection symptom with greenish discharge per nose or periorbital swelling 2.3 double sickening of upper respiratory infection symptoms
Exclusion Criteria
2. patient who has complication of sinusitis
3. patient with a history of nasal anatomical defects
4. patient who has immune deficiency or primary ciliary dyskinesia
3 Years
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Thammasat University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
araya satdhabudha
clinical professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Araya Satdhabudha, MD
Role: PRINCIPAL_INVESTIGATOR
Thammasat University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Araya Satdhabudha
Klongluang, Pratumthanee, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
45/2555
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
ทป 45/2555
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.